Literature DB >> 10548409

Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.

R T Jensen1.   

Abstract

Eight different neoplastic disorders can cause chronic diarrhea attributable to humoral-mediated diarrhea. These include pancreatic endocrine tumor (PET) syndromes (gastrinomas, VIPomas, glucagonomas, somatostatinomas, PET's releasing calcitonin), carcinoid syndrome, medullary thyroid cancer, and systemic mastocytosis. Because these disorders are an uncommon cause of all chronic diarrheas (<1%), they are not often considered in the differential diagnosis, leading to a delay in diagnosis. This is problematic not only because all are treatable, but also because the neoplasm is frequently malignant. In this article, the characteristics and pathogenesis of the diarrhea, important clinical and diagnostic laboratory features, and treatment of each disorder are briefly reviewed, with an emphasis on recent insights.

Entities:  

Mesh:

Year:  1999        PMID: 10548409

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


  12 in total

Review 1.  Intestinal ion transport and the pathophysiology of diarrhea.

Authors:  Michael Field
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Healthcare and economic impact of diarrhea in patients with carcinoid syndrome.

Authors:  Michael S Broder; Eunice Chang; Dorothy Romanus; Dasha Cherepanov; Maureen P Neary
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

3.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

4.  2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors:  M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal:  Eur Thyroid J       Date:  2012-03-28

Review 5.  Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.

Authors:  Fathia Gibril; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2004-12

6.  Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study.

Authors:  Ramona Dadu; Mimi I Hu; Charles Cleeland; Naifa L Busaidy; Mouhammed Habra; Steven G Waguespack; Steven I Sherman; Anita Ying; Patricia Fox; Maria E Cabanillas
Journal:  Thyroid       Date:  2015-08-20       Impact factor: 6.568

Review 7.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

8.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

9.  A Pancreatic Polypeptide-Producing Pancreatic Tumor Causing WDHA Syndrome.

Authors:  Vera Amrilleva; Emily P Slater; Jens Waldmann; Dorothee Bonorden; Volker Fendrich
Journal:  Case Rep Gastroenterol       Date:  2008-07-09

10.  Treatment of advanced medullary thyroid cancer.

Authors:  Johannes Smit
Journal:  Thyroid Res       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.